PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26345972-1	2015	We investigated the association between the polymorphisms GSTP1 rs1695 and XRCC1 rs1799782 and rs25487 and the clinical outcome of patients with non-small cell lung cancer (NSCLC) receiving cisplatin-based chemotherapy.	Cisplatin	190-199	X-ray repair cross complementing 1	Homo sapiens	75-80	
26345972-5	2015	The results of our study suggest that the GSTP1 rs1695 and XRCC1 rs25487 polymorphisms might affect the clinical outcome of patients with advanced NSCLC receiving cisplatin-based chemotherapy.	Cisplatin	163-172	X-ray repair cross complementing 1	Homo sapiens	59-64